During the past decade, St. Mary's Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Mary's Hospital" #1 sponsor was "Pfizer" with 4 trials, followed by "Bayer" with 3 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Mary's Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "St. Mary's Hospital" are "Anemia" (2 trials), "Colorectal Cancer" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Acute Non-cardioembolic Ischemic Stroke" (1 trials). Many other conditions were trialed in "St. Mary's Hospital" in a lesser frequency.

Most popular intervention types in "St. Mary's Hospital" are "Drug" (10 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "BAY2433334" (1 trials) and "BAY2433334 matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Mary's Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "St. Mary's Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in St. Mary's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Mary's Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".